Staging of rectal cancer by double-contrast MR imaging using the rectally administered superparamagnetic iron oxide contrast agent ferristene and IV gadodiamide injection: Results of a multicenter phase II trial. (vol 12, pg651, 2000)
Ag. Maier et al., Staging of rectal cancer by double-contrast MR imaging using the rectally administered superparamagnetic iron oxide contrast agent ferristene and IV gadodiamide injection: Results of a multicenter phase II trial. (vol 12, pg651, 2000), J MAGN R I, 13(3), 2001, pp. 481-481